NL-OMON38672已完成不适用
Early clinical feasibility study of a new voice prosthesis: the Provox Vega HP - Provox Vega HP study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Laryngectomized patients using either the Provox Vega or the Provox ActiValve Light voice prosthesis, with a length of 6, 8, or 10 mm
- •Age: 18 years or older
排除标准
- •-Current tracheoesophageal puncture problems such as enlarged puncture or infection
- •-Active recurrent or metastatic disease (medical deterioration)
- •-Unable to understand the patient information and/or unable to give informed consent
研究者
相似试验
已完成
不适用
Early clinical feasibility study of a new voice prosthesis: the Provox Vega HPNL-OMON50825Atos Medical AB20
已完成
不适用
Clinical Feasibility of a New Voice ProsthesisLaryngectomyNCT05079386Atos Medical AB17
已完成
不适用
An early clinical feasibility study of a new prosthesis: the NewBreez® Intralaryngeal device; a possible solution for severe aspiration in head and neck cancer patientsaspirationDysfunctional larynxswallowing impairment10027656NL-OMON42228Antoni van Leeuwenhoek Ziekenhuis5
终止
不适用
Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice ProsthesisTotal LaryngectomyNCT00661570Atos Medical AB26
已完成
2 期
Phase 2 clinical feasibility study of a new Speaking Valve with a heat- and moisture exchanger (TW) for tracheotomized patients.tracheostomyairway openingTracheotomy10046304NL-OMON38448Atos Medical AB20